From Akebia Therapeutics's results release of 2026年11月5日; its quarterly report has since been filed.

• Revenue

  Actual

  $36.9M

  -37% y/y ↓
  -25% q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  -$0.05

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -$11.5M

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.